##
|Trustees and advisors|||
|---|---|---|
|Board ofTrustees'
report||2-13|
|Independent
auditor's|report|14-16|
|Statement offinancial|activities|17|
|Summary
income and|expenditure|19|
|Balance sheet||20|
|Statement ofcash flows||21|
|Notes to the financial|statements|22-38|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|Difficult economic environment|Difficult economic environment|Difficult economic environment|Monthly|SMT review of income and|SMT review of income and|expenditure;|
|---|---|---|---|---|---|---|
|significantly|impacts financial|security of|Fundraising||Strategy and increased|capacity
in|
|organisation.|||Fundraising||Team; Finance and Fundraising
reports to||
||||FKGP.||||
|Reserves|and cash position|insufficient|Reserves||policy reviewed
annually|by F8GP; cashflow|
|to meet commitments.|||report quarterly
to FKGP; medium
term strategy to build||||
||||reserves.||||
##
##
##
##
##
##
##
##
##
|ical Advisory
Group provides
invaluab
rent members
ofthis group are:|le
clinical advice to inform and|
|---|---|
|Dr Kate Adams|Dr Adrian Palfreeman|
|Professor Jane Anderson|Nicky Perry|
|Dr Tristan Barber|Dr lain Reeve|
|Dr Dan Clutterbuck|Dr Ann Sullivan|
|Ceri Evans|Dr Shema Tariq|
|Dr William
Ford-Young|Dr Steve Taylor|
|Jamie Hardie|Dr Lee Winter|
|Dr Christian Jessen|Sarah Zetler|
|Eileen Nixon||
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|Current financial year|||||||
|---|---|---|---|---|---|---|
|||Unrestricted|Restricted|Endowment|Total|Total|
|||funds|funds|funds|||
||Notes|2022-23
f|2022-23|2022-23|2022-23f|2021-22|
|Income from:|||||||
|Donations
and legacies|3|514,104|306,490||820,594|663,454|
|Charitable
activities|4|307,757|||307,757|157,241|
|Investments|5|5,318||2,427|7,745|2,897|
|Total income and endowments||827,179|306,490|2,427|1,136,096|823,592|
|~E*
Cht|||||||
|Raising funds|6|288,377||840|289,217|194,166|
|Charitable
activities|7|520,900|323,477||844,377|781,588|
|Total expenditure||809,277|323,477|840|1,133,594|975,754|
|Net movement
in funds||17,902|(16,987)|1,587|2,502|(152,162)|
|Fund balances at 1 July 2022||531,098|115,325|259,242|905,665|1,057,827|
|Fund balances at30June 2023||549,000|98,338|260,829|908,167|905,665|
##
##
##
|Prior financial|year||||||
|---|---|---|---|---|---|---|
||||Unrestricted|Restricted|Endowment|Total|
||||funds|funds|funds||
||||2021-22|2021-22|2021-22|2021-22|
|||Notes|6|6||f|
|Income from:|||||||
|Donations
and|legacies||427,141|236,313||663,454|
|Charitable
activities|||157,241|||157,241|
|Investments|||2,804|93||2,897|
|Total income and endowments|||587,186|236,406||823,592|
|~E«dit|||||||
|Raising funds||6|194,166|||194,166|
|Charitable
activities||7|585,487|196,101||781,588|
|Total expenditure|||779,653|196,101||975,754|
|Net movement|in funds||(192,467)|40,305||(152,162)|
|Fund balances|at1 July 2021||723,565|75,020|259,242|1,057,827|
|Fund balances at 30June 2022|||531,098|115,325|259,242|905,665|
##
##
##
||||2022-23|2021-22|
|---|---|---|---|---|
|||||f|
|Gross income|||1,133,669|823,592|
|Total expenditure|from income funds||1,132,754|975,754|
|Net income/(expenditure)||forthe year|915|(152,162)|
##
##
##
||||2022-23|2021-22|
|---|---|---|---|---|
|||Notes|f||
|Fixed assets|||||
|Tangible assets||13|18,786|10,546|
|Endowment
investment||14|260,829|259,242|
||||279,615|269,788|
|Current assets|||||
|Stocks||15|13,961|13,939|
|Debtors falling due|after one year|16|4,136|4,136|
|Debtors falling due|within one year|16|227,473|198,781|
|Cash at bank and|in hand||568,879|480,623|
||||814,449|697,479|
|Creditors: amounts
falling due within|||||
|one year||17|(185,897)|(61,602)|
|Net current assets|||628,552|635,877|
|Total assets less|current liabilities||908,167|905,665|
|Capital funds|||||
|Permanent
endowment||21|260,829|259,242|
|income funds|||||
|Restricted funds||23|98,338|115,325|
|Unrestricted
funds|—general||549,000|531,098|
||||908,167|905,665|
##
##
##
||||||2022-23||2021-22|
|---|---|---|---|---|---|---|---|
|||||Notes|'Z|||
|Cash flows from operating||activities||||||
|Cash generated
from/(absorbed
operations|||by)|27||99,402|(313,058)|
|Investing
activities||||||||
|Purchase oftangible fixed|assets||||(17,305)||(7,075)|
|Proceeds on disposal oftangible
assets|||fixed||||156|
|Interest received|||||7,745||2,897|
|Net cash used in investing||activities||||(9,560)|(4,022)|
|Net increase/(decrease)
equivalents|in|cash and cash||||89,842|(317,080)|
|Cash and cash equivalents||at beginning||ofyear||739,865|1,056,945|
|Cash and cash equivalents||at|end ofyear|||829,708|739,865|
|Relating to:
Cash at bank and in hand||||||568,879|480,623|
|Deposits included
in fixed
-endowment|asset||investments|||260,829|259,242|
|||||||829,708|739,865|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|Donations and legacies||||
|---|---|---|---|
|||Total|Total|
|||2022-23|2021-22|
|||8|f|
|Grants (E5,000+)plus all pharmaceutical
Other grants and donations
Donated goods and services|grants|362,371
457,100
1,123|340,833
274,358
48,263|
|||820,594|663,454|
##
##
##
##
||||||
|---|---|---|---|---|
|Donations
and legacies||||(Continued)|
||||2022-23|2021-22|
||||8|f|
|Grants (F5,000+)plus all|pharmaceutical|grants|||
|Gilead Sciences Ltd|||15,538|72,988|
|The Baring Foundation|||31,200||
|IAS Society|||8,982||
|Viva Glam||||50,000|
|ViiV Healthcare
UK Limited|||89,663|89,663|
|National
Lottery Fund|||81,588||
|Mill Charitable
Trust|||20,000|30,000|
|Trust for London|||60,000|8,500|
|Martin Bowley Charitable
Trust|||5,000||
|City Bridge Trust|||12,390|23,500|
|Janssen-Cilag
Ltd||||4,000|
|Merck, Sharpe &Dohme Ltd|||1,250||
|Swarovski
Foundation||||42,850|
|Africa Advocacy|||36,761|11,250|
|Paper and Pixels donated|WAD website|||4,000|
|Latham 8 Watkins donated|legal services|||44,263|
|The Evan Cornish Foundation||||8,082|
||||362,371|389,096|
|Other grants and donations|||||
|Individual
8 community|||133,765|102,888|
|Corporate
donations|||283,358|85,557|
|Trusts 8 foundations||||3,260|
|Legacies|||39,977|82,653|
||||457,100|274,358|
##
##
##
|||||||2022-23|2021-22|
|---|---|---|---|---|---|---|---|
|||||||f.|f|
|European
international|project funding|||||141,049|130,223|
|Royal Free London NHS Foundation|||Trust||—Fast Track Cities|131,215||
|Gilead Sciences Ltd &|ViiV|Healthcare||UK|Ltd joint HIV outcomes project|98,000||
|Less; deferred
income||||||(90,326)||
|||||||279,938|130,223|
|Awareness
raising through||red dbbon||products||24,837|22,366|
|Other income||||||2,982|4,652|
|||||||307,757|157,241|
##
##
|||Endowment|Total|
|---|---|---|---|
|||funds||
|||2022-23|2021-22|
|||F||
|Interest|receivable|2,427|2,897|
##
|Raising fu|nds||||||
|---|---|---|---|---|---|---|
||||Unrestricted|Endowment|Total|Total|
||||funds|funds|||
||||general||||
||||2022-23|2022-23|2022-23|2021-22|
||||||f|f|
|Fundraising|salaries||167,169||167,169|119,473|
|Associated|operating|costs|34,434||34,434|17,174|
|Support costs|||86,774||86,774|57,519|
|Charitable|fundraising|costs|288,377||288,377|194,166|
|Endowment|legal fees||||840||
||||288,377|840|289,217|194,166|
##
##
|7|Charitable
activities||||
|---|---|---|---|---|
||||2022-23|2021-22|
||||f||
||Policy work 8 campaigning||||
||Staff costs||427,130|448,006|
||Other direct charitable|expenditure|133,497|69,880|
||||560,627|517,886|
||Share ofsupport costs (see note 10)||221,713|215,687|
||Share ofgovernance|costs (see note 10)|62,037|48,015|
||||844,377|781,588|
||Analysis
by fund||||
||Unrestricted
funds - general||520,900|585,487|
||Restricted funds||323,477|196,101|
||||844,377|781,588|
##
||||2022-23|||2021-22|
|---|---|---|---|---|---|---|
||||F|||8|
||Direct|Support|Total|Direct|Support|Total|
||Charitable|Costs|Costs|Charitable|Costs|Costs|
|Stop|123,338|62,425|185,763|160,545|81,748|242,292|
|Champion|50,456|25,538|75,994|56,967|29,007|85,975|
|Protect|207,432|104,988|312,419|108,756|55,377|164,133|
|Drive|179,401|90,800|270,201|191,618|97,570|289,188|
||560,627|283,750|844,377|517,886|263,702|781,588|
##
##
##
|Support costs||||||||
|---|---|---|---|---|---|---|---|
|||Support|Governance|2022-23 Support|costs|Governance|2021-22|
|||costs|costs|||costs||
|||f||||||
|Staff costs||161,899|52,189|214,088|91,878|39,629|131,507|
|Depreciation||9,064||9,064|13,072||13,072|
|Non salary staffing &
recruitment
costs||41,498||41,498|17,926||17,926|
|Office expenditure||9,261||9,261|6,436||6,436|
|Telephone
&internet
Website & IT||2,790
27,716||2,790
27,716|3,562
26,279||3,562
26,279|
|Premises expenditure||50,971||50,971|64,795||64,795|
|Insurance||3,066||3,066|2,797||2,797|
|Professional
fees||2,222||2,222|2,498||2,498|
|Donated legal fees for
office move|||||43,963||43,963|
|Audit fees|||7,200|7,200||6,960|6,960|
|Legal and professional|||339|339||724|724|
|Trustees' meetings
training|and||2,309|2,309||702|702|
|||308,487|62,037|370,524|273,206|48,015|321,221|
|Analysed
between
Fundraising||86,774||86,774|57,519||57,519|
|Charitable
activities||221,713|62,037|283,750|215,687|48,015|263,702|
|||308,487|62,037|370,524|273,206|48,015|321,221|
##
##
##
##
##
|Number ofe
The average|mployees
staff headcount
duding the year was as follows:|||
|---|---|---|---|
|||2022-23|2021-22|
|||Number|Number|
|||20|19|
|Employment|costs|2022-23|2021-22|
|||f||
|Wages and salaries||699,753|604,578|
|Social security costs||69,190|57,795|
|Other pension costs||39,444|36,613|
|||808,387|698,986|
|||Total|Total|
|Employment|costs by department|2022-23|2021-22|
|||f|f|
|Core policy work||427,130|448,006|
|Fundraising||167,169|119,473|
|Support &governance||214,088|131,507|
|||808,387|698,986|
##
|2022-23|2021-22|
|---|---|
|Number|Number|
|1|1|
##
##
|13|Tangible fixed assets|Tangible fixed assets||||
|---|---|---|---|---|---|
||||Equipment,|fixtures and fittings||
||Cost|||||
||At 1 July 2022
Additions||||77,623
17,305|
||Disposals||||(5,841)|
||At 30June 2023||||89,087|
||Depreciation
and impairment|||||
||At 1 July 2022
Depreciation
charged|in the year|||67,078
9,064|
||Eliminated
in respect|ofdisposa le|||(5,841)|
||At 30June 2023||||70,301|
||Carrying amount
At 30June 2023||||18,786|
||At 30June 2022||||10,546|
|14|Fixed asset investments|||||
||||||Cash|
||||||E|
||Cost or valuation|||||
||At 1 July 2022 8 30June 2023||||259,242|
||Carrying amount|||||
||At 30June 2023||||259,242|
||At 30June 2022||||259,242|
|15|Stocks|||||
||||2022-23
E||2021-22f|
||Stocks ofRed Ribbon lapel pins and brooches||13,961||13,939|
##
##
|16|Debtors|||||
|---|---|---|---|---|---|
|||||2022-23|2021-22|
||Amounts
falling due|within one year:||f||
||Grants and donations|invoiced||207|5,900|
||VAT recoverable|||7,499||
||Donations and grants|accrued income||165,154|117,091|
||Legacies due|||38,977|62,383|
||Prepayments|||15,636|13,407|
|||||227,473|198,781|
|||||2022-23|2021-22|
||Amounts
falling due|after more than one year:||f||
||Rent deposit|||4,136|4,136|
||Total debtors|||231,609|202,917|
|17|Creditors: amounts|falling due within one year||||
|||||2022-23|2021-22|
||||Notes|f|f|
||Other taxation and social security|||14,790|19,143|
||Deferred income||18|90,326||
||Trade creditors|||29,086|8,382|
||Other creditors|||2,393|1,694|
||Accruals and other creditors|||49,302|32,383|
|||||185,897|61,602|
|18|Deferred income|||||
|||||2022-23|2021-22|
||Arising from deferred|income||90,326||
##
##
##
|non-cancellable
operating
leases, which
fall due as follow|s:||
|---|---|---|
||2022-23|2021-22|
||2|f|
|Within one year
Between two and five years|14,829
339|38,754
11,595|
||15,168|50,349|
##
||||Movement||Movement||
|---|---|---|---|---|---|---|
||||in funds||in funds||
|||Balance at|Incoming|Balance al|Incoming|Balance at|
|||1 July 2021
6|resources|1July 2022
f|resources
6|30June 2023
6|
|Permanent|endowments||||||
|Gary Philipp|Endowment|259,242||259,242|2,427|260,829|
|||259,242||259,242|2,427|260,829|
##
##
##
|22|Total return on endowment|Total return on endowment|Total return on endowment|||||
|---|---|---|---|---|---|---|---|
||Opening|value ofendowment:|||||259,242|
||Unapplied||total return|||||
||Total||||||259,242|
||Movement||in unapplied
total||return and endowment|in the year:||
||Investment||return: dividends|and interest|||2,427|
||Investment||management
costs||—legal fees to establish|the fund|(840)|
||Total||||||1,587|
||Unapplied||total return allocated||to income|||
||Net movement
in the reporting||||period||1,587|
||Closing value ofpermanent|||endowment||||
||Gift component
ofpermanent|||endowment|||259,242|
||Unapplied||total return||||1,587|
||Total||||||260,829|
||||e N
0 O
0 td
C Q
Id 0|e N
0 O
0 td
C Q
Id 0|C!|||||||||||||||||||O
O
0O|0|O
N
N
(D||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||e|||||||||||||||||||||||||||
||||CI|||||||||||||||||||||||||||
||||O D||||||Cd
Cl|||||||||||||||O
OO
O|O
0
Cd|||||
|||||Cd||||||||||||||||||||||||||
||||Ol
C|N
III|O
Cd
tD|||||||||||||dC
Cd|||O
Q|Cd
CO
ID||QC!
CD||CD
(D|||O
Cd|
||||||N
(0||||||||||||||||«I|Cd||C||Ol
CD|||(D
C!|
||||N0
N0
Ct
C|N
dl||||||||||||||||||||||||||
||||O.0
m
Cl|N
cd
O|OlC||||||||||||||||||||O R||0||O|
||||V|Cd||||||||||||||||||||||||||
||||K.
e|N||||||||||||||||||||||||||
||||g|I||||||||||||||||||||||||||
||||N|||||||||||||||||||||||||||
||||00
11e
ld
0|'g 0!
D|O
Q
IO
CO
Cd
Cd||Q
O||O||||O
Cd|||||to
tg
al
N
O
0
«!|||||||CD
Cd
Q
«I
CN||||Cd
CD
CD
Cd|
||||at0
g|Lc||||||||||||||||||||||||||
||||ttl|||||||||||||||||||||||||||
||||Ot
1«0
tll
NC0
Ol
0
Pp|N
Cl
0
N|O
O
Q
0
(D
N
O
N||O
Q
I
0||N
CD
0
«I||||Q
«I||0!
CD||Cl
Cd
al
ID|o
d
O
Cd||||||CO|te
al
tD
ID
N
Ol
C
(D|||o
0!|te
C!
(D
Cd|
||||a!00
—E|||||||||||||||||||||||||||
||||0
h
0
ta
C
al
e
dl
V
L
Id|td
O
N|||||||(O
C!
Cd|||Ct||||||ID
N
O
O O||||O
ca
Cd||||CI
C
D
Cd||
||||Id
Jd|I||||||||||||||||||||||||||
||||11|||||||||||||||||||||||||||
||||tll|||||||||||||||||||||||||||
||||(UO.|||||||||||||||||||||||||||
|O|||Q
IC
L|||||||||||||||||||||||||||
|UlDZI-Z0
O
LoI-Z
IU
UlI-
I-
Ill
OZ
Z
U
LU
I-0I-
M
ILII-0Z|Plo
Al
Ul
Ch
a
LUa
LU
U.0|e
'D
L
'D00
ID0
IL|ca0
0
td
Ol0
N
Ct
E
0
N'00
td
dl0
Q
0
1d
C
ld
0
Q
0
N
1d0
d!
E
8E
dt||Q
Z
N
L
0
0C
0
al
I—
td
Cd
1d
th
CJ|E
U.
N
dl
(J
at
(d
0
at
!—
dt
Ot
CD
O
N
NO
O
0!
d!
ad
dl
0
C
dl0
CJ||||'D
td
tll0
E
Q
al
Q0
N
a!
C
E
CJ
L0
m
0
0
IL
N
L
CJ
L
m
UJ||X0|0
D.
m
E c
Cl
«C
ld)
L
Z|||OlL
N
dt
0
Yl0
1dC
dle
Q
I!'.
ca
1«L
dt0.
CD
Q
0
Q
Q
CtE
CJ
D '0
tt!
td
dt
td|||m
Ep
(0
ca
L-
'0
C
UJ
al
dl
8|dt
O!0
dtO
dl
10
td
N
dl
Val
td
ID
at
E
&
(!
0
0
al
—
tll
'd!
'oc
E|ld
a!
ca
0
td
c
0
0
Ol
L
m
ID|0
a
C
L
E
0
CU
c
D
C
0
IL
Ot
0
'0
td
tll
e|N
dt
0
tll
Dl0
UJo
0
IL
0
E
E
CJ
0
tll
0
0
ttl
Z
eC|o
m
E
d
)
Z
0
0
D
C
0|It!
a
0
NO
m
0 Z
OI)
2 Z
Ol
m c
a—
E c
0
td
L
IU0 0
0
ttt
C '0
0 0
DL 0
0
IL
N
0
N
af
I-
CD||0
0
Q
td
o
C
dl|00
tll
E
0
N
d
td
E
Ol
N
DlE
a!
JD
E
0
c
0
UJ
a
0
C
L
(3||
|||||||||||ID||L|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||||||||Gl|
||||"0
Cl|||||||Ql
Ql||0|
||||0
00O||Z||||S3
ID|tD
0
O.
E||0O.
O.
Ul
0|
||||||Ut||||CD|0|||
||D|||Z
N3
Ul
'L
& in
0 C
40 E
Ul E
0!a O
E h(
&0
O
m
O (0
&h
Ul0
S
O
Ul a
c E
'E0 0
O. Ql
a'0
N
ID0
Gl
ao
Ol
C C
Ql
C.&
El
N
0 D
m L
LU IL|C
Gl
Z
3
Ol
N
C
Gl
Ol
E
0
N
Ol
0
Ol
C
Ut
&0
CL
E
&00)
DT
0 Zc
3
0
CD
0
O.
3 0S
Cl.& 0
Ol
&h E
D
Ql
C
&0(1.
MS
NC
Ql
Gl
O.
E0O
Gl
CD
0
Ct
C
Ql
E
N
tU
&" E
C .Ol
gl
N
O D
C
ID
gl
0 O
00 0
0
CI
3
m
&n
N
'0
O
m
&0
0 0
L C
&0
Gt
CD Ol
Ut
tUS
&h0
40)E
Z
m
5 D
CD C0!S
Qt 0
O«
a
&0
O 0S
Ol
Ql
ln
N 0
o a
N.E
0—
L0
Gl
ID
NEW
e'
&h 0 00
Ql S
a
0
eX«m
ID
omo
S CI
O
m
&0
"SN
CL
N 0
&0
0
CD O 0
L
Ql
N
D 0'0
C a L
IL
QC u
E
Ql
N
N
Gt
Ql
Gl0)
x—
SZ
N40
WL
C 0
N
x
In
aE
E
Ul
tU
0
N3
a S
ED
&0 C
C S0
Ot
C M
&0cn 3
Qt
E &E
N
Ih
'O D
m
&0
0 C
tg
O CD
00.
CI
Ul
I/l
C
C
Gl D
Ql C
C 0
—O
Gl
L 0
Ql
E 0
0 DL
N
QlC—
0 3
" Ul
00.'
0
m e
O NS
O.
.E
In0
SC
0 0
Ul00—
UtS
In)
O Z
m3
In
0
mS
C
m 0
O (1
Gl
Ql
0
L0
&D0
O.
O.
&U
o 3
QDE c
C 0 0
N 'c
&0
S C
S 0 E
D) 0
N
tU
N 0—
Ql
Ql C
CD &0
S 0
0 D
m 0
N~
m
«0
&U 0
CD C
&D O
ID
010
CD
N
N
Ul D
C —L
N
u Du
0
&U)
EZ
'L C
0.
In
N) C
Z
m
4
Ul
0 '
NE
S
N
m 0
Gl
0
0
m
C! C
am
N S
mc
CDS
UlL
Ul 'c E
tg
L 40
ID
IL IY|||||||Gt
Z
0
O O
O O
gg
(&I
0 C
0 0
N
N
N
N
E E
C
Gl
&0
Z Z
3 3
Ql SC
D D
C C
S
Gl
0 0
0 0
0 0
CI CI
Ql
Ql
a o.
&0
&0
N
N
0 0
0 0
Gl S
0 0
CI O.
&0
Gl
N
N
&0
m
3 3
0 0
CD OlLD
C L
IL IL
0
&D
N
E
Gl
&nN
Ql
0
ID
0
ln
Gl
N(000
0
Gt0a
C!.
(0
uf
CL0
O
S
ID C
Ut
&U
0 '
0 CI
E E
m
0 O
&D
0 Ul|
||ZI-z0V|||||||||Cl'0
N|||
|||||||||||'U|||
||CIII-z
IU|Io!|||Cl
N|||||L
IU
Ol
& C
0 Iu||0!|
||III|CD
C(4||0
0|UlS0|||||oO
IL IL||Gl
E
ID
0|
|(0
(n
o
z
0
Z|e
z
0
zE
IL
IUzI-
o
I-
ILI
o
Z|LII
5
o
g
a
III
~
4J
o
II.|&0
C
'0S0
W
Cl
&4|BO
N
N
&tl
0
0)
0
IO
0 S
0c c
N
W
Cl S
Ul Ol
10 'U
IO Io
OO|N
mC
E
O
C0
ln0
m
O DL
lg
Cg 00
—IL
olj L
Ul
0 E
SO
m
0O Iu
Ol
C
&0
cg
CI|C
Gla 44
Gl
0 4l
0
&0
&«e
ZK
X
0
a
X||Ol
E
0!
S
4
0
IO0
C|C0 '0
ID
&0cu.c.c
&, 0 c
,E
—ot
L"
&0
Gl
0 Ufo.
Ul.
E —E
~S CI E E e
oo5 0
m
N c CO& e
E 0 0,0
—o
Emm
Ufo'
'
2'Z 0
4l
ugccc
CC
01OUUOOO
CCOO-IDD
NIL IL
C c
L
W OtotLgg
Gl 0 0
lu
m
C C 0
0'i'i
0 0
DD mern«.
o-
m —IO IO Z
S S
Ul
N
=Dicer 22
5 C I- I- I- I- I"-
Cl
IL
UlC'0
L
Cl0!.
V!
S
N
LS
J
S
E
O|||&g
N
Z
Ul
C
Z
ea
c
E0
DCO
Iu .
C
cee
ogE
2
mo. 0
'0CSC
0
Gt
02(uc
0 0
C am
In
m 'C.—
m& 2'0
Gl
Ul
uf)Q "6|
##
##
##
|Analysis ofnet assets between funds|Unrestricted|Restricted|Endowment|Total|
|---|---|---|---|---|
||funds|funds|funds||
||2022-23f|2022-23f|2022-23
F|2022-23f|
|Fund balances at30 June 2023 are represented|||||
|by:|||||
|Tangible assets
Investments|18,786||260,829|18,786
260,829|
|Current assets/(liabilities)|530,214|98,338||628,552|
||549,000|98,338|260,829|908,167|
||Unrestricted|Restricted|Endowment|Total|
||funds|funds|funds||
||2021-22f|2021-22f|2021-22
f|2021-22
f|
|Fund balances at30 June 2022 are represented|||||
|by:|||||
|Tangible assets
Investments|10,546||259,242|10,546
259,242|
|Current assets/(liabilities)|520,552|115,325||635,877|
||531,098|115,325|259,242|905,665|
##
##
##
##
##
|27|Cash generated
from operations|Cash generated
from operations|||||2022-23|2021-22|
|---|---|---|---|---|---|---|---|---|
||Surplus/(deficit)
forthe year||||||2,502|(152,162)|
||Adjustments
for:||||||||
||Investment
income recognised|in|statement||offinancial|activities|(7,745)|(2,897)|
||Depreciation
and impairment|oftangible||fixed assets|||9,064|13,072|
||Movements
in working capital:||||||||
||(Increase)/decrease
in stocks||||||(22)|8,454|
||(Increase) in debtors||||||(28,692)|(126,319)|
||Increase/(decrease)
in creditors||||||33,969|(53,206)|
||Increase
in deferred
income||||||90,326||
||Cash generated
from/(absorbed||by) operations||||99,402|(313,058)|